Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Teneligliptin/Metformin FDC vs Co-administration in Healthy Volunteers
NCT03787017Phase 1Completed
- Sponsor
- Handok
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of teneligliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Handok. Primary endpoints: Area Under the Curve and Maximum Plasma Concentration. Started Jan 2014; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03787017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787017.